-
1 Comment
Henry Schein, Inc is currently in a long term uptrend where the price is trading 12.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.
Henry Schein, Inc's total revenue rose by 18.6% to $3B since the same quarter in the previous year.
Its net income has dropped by 56.8% to $143M since the same quarter in the previous year.
Finally, its free cash flow grew by 27.7% to $339M since the same quarter in the previous year.
Based on the above factors, Henry Schein, Inc gets an overall score of 4/5.
Sector | Healthcare |
---|---|
Exchange | F |
CurrencyCode | EUR |
ISIN | US8064071025 |
Industry | Medical Distribution |
Market Cap | 7B |
---|---|
Beta | 0.85 |
PE Ratio | 21.09 |
Target Price | 83.5 |
Dividend Yield | None |
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers. The company serves customers in dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for HS2.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025